Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Milk, Human | 59 | 2025 | 187 | 13.830 |
Why?
|
Breast Feeding | 56 | 2025 | 162 | 11.910 |
Why?
|
Infant, Very Low Birth Weight | 50 | 2022 | 177 | 10.560 |
Why?
|
Intensive Care Units, Neonatal | 59 | 2025 | 194 | 9.440 |
Why?
|
Infant, Premature | 60 | 2025 | 207 | 8.720 |
Why?
|
Mothers | 40 | 2025 | 180 | 8.160 |
Why?
|
Infant, Newborn | 108 | 2025 | 596 | 6.250 |
Why?
|
Lactation | 23 | 2023 | 56 | 5.190 |
Why?
|
Breast Milk Expression | 13 | 2020 | 39 | 4.960 |
Why?
|
Intensive Care, Neonatal | 11 | 2020 | 34 | 3.180 |
Why?
|
Infant Nutritional Physiological Phenomena | 28 | 2025 | 75 | 3.170 |
Why?
|
Infant | 29 | 2025 | 522 | 2.220 |
Why?
|
Enterocolitis, Necrotizing | 11 | 2020 | 47 | 2.110 |
Why?
|
Female | 79 | 2025 | 14411 | 1.910 |
Why?
|
Mother-Child Relations | 7 | 2017 | 31 | 1.790 |
Why?
|
Humans | 111 | 2025 | 26049 | 1.740 |
Why?
|
Child Development | 10 | 2020 | 73 | 1.590 |
Why?
|
Infant, Premature, Diseases | 7 | 2020 | 29 | 1.520 |
Why?
|
Neonatal Nursing | 12 | 2018 | 17 | 1.490 |
Why?
|
Gestational Age | 16 | 2020 | 80 | 1.380 |
Why?
|
Peer Group | 6 | 2017 | 35 | 1.360 |
Why?
|
Social Support | 6 | 2019 | 182 | 1.250 |
Why?
|
Maternal Behavior | 4 | 2017 | 11 | 1.230 |
Why?
|
Bronchopulmonary Dysplasia | 3 | 2019 | 16 | 1.150 |
Why?
|
Adult | 38 | 2025 | 7367 | 1.100 |
Why?
|
Milk Banks | 6 | 2020 | 22 | 1.020 |
Why?
|
Bottle Feeding | 8 | 2016 | 14 | 1.020 |
Why?
|
Patient Discharge | 9 | 2025 | 151 | 1.010 |
Why?
|
Health Care Costs | 5 | 2020 | 72 | 1.010 |
Why?
|
Prospective Studies | 18 | 2019 | 1663 | 0.980 |
Why?
|
Counseling | 5 | 2013 | 41 | 0.910 |
Why?
|
Postpartum Period | 3 | 2021 | 22 | 0.890 |
Why?
|
Goals | 4 | 2017 | 39 | 0.870 |
Why?
|
Infant, Low Birth Weight | 7 | 2019 | 16 | 0.840 |
Why?
|
Male | 37 | 2025 | 14025 | 0.830 |
Why?
|
Precision Medicine | 1 | 2022 | 25 | 0.810 |
Why?
|
Infant, Newborn, Diseases | 4 | 2020 | 14 | 0.810 |
Why?
|
Socioeconomic Factors | 4 | 2020 | 290 | 0.760 |
Why?
|
Postnatal Care | 2 | 2013 | 7 | 0.740 |
Why?
|
Healthcare Disparities | 2 | 2020 | 81 | 0.710 |
Why?
|
Educational Status | 5 | 2019 | 286 | 0.710 |
Why?
|
Social Determinants of Health | 1 | 2020 | 33 | 0.700 |
Why?
|
Nutritive Value | 5 | 2020 | 21 | 0.690 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 22 | 0.670 |
Why?
|
Enteral Nutrition | 4 | 2018 | 59 | 0.670 |
Why?
|
Health Promotion | 4 | 2013 | 147 | 0.670 |
Why?
|
Contraception Behavior | 1 | 2019 | 4 | 0.660 |
Why?
|
Sepsis | 3 | 2019 | 138 | 0.620 |
Why?
|
Anthropometry | 6 | 2007 | 35 | 0.610 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2019 | 176 | 0.590 |
Why?
|
Hospitalization | 6 | 2019 | 294 | 0.580 |
Why?
|
Birth Weight | 7 | 2020 | 43 | 0.580 |
Why?
|
Chicago | 7 | 2017 | 845 | 0.570 |
Why?
|
Stress, Psychological | 2 | 2019 | 212 | 0.560 |
Why?
|
Child Language | 2 | 2017 | 12 | 0.560 |
Why?
|
Resilience, Psychological | 1 | 2017 | 22 | 0.540 |
Why?
|
Infant Care | 6 | 2016 | 18 | 0.530 |
Why?
|
Depression, Postpartum | 2 | 2017 | 13 | 0.530 |
Why?
|
Puerperal Disorders | 1 | 2015 | 6 | 0.500 |
Why?
|
Infant Formula | 6 | 2020 | 22 | 0.490 |
Why?
|
Young Adult | 7 | 2019 | 1853 | 0.490 |
Why?
|
Retrospective Studies | 12 | 2025 | 3305 | 0.490 |
Why?
|
Longitudinal Studies | 8 | 2019 | 1344 | 0.480 |
Why?
|
Cost Savings | 1 | 2015 | 30 | 0.480 |
Why?
|
Weight Gain | 5 | 2018 | 61 | 0.470 |
Why?
|
Suction | 3 | 2010 | 37 | 0.470 |
Why?
|
Energy Intake | 4 | 2018 | 71 | 0.460 |
Why?
|
Research Support as Topic | 2 | 2005 | 12 | 0.460 |
Why?
|
Infant, Extremely Low Birth Weight | 3 | 2012 | 21 | 0.460 |
Why?
|
Motor Activity | 2 | 2017 | 314 | 0.460 |
Why?
|
Retinopathy of Prematurity | 1 | 2014 | 6 | 0.460 |
Why?
|
Anxiety Disorders | 1 | 2015 | 157 | 0.450 |
Why?
|
Patient Education as Topic | 5 | 2013 | 140 | 0.450 |
Why?
|
Intestines | 2 | 2013 | 94 | 0.450 |
Why?
|
Hospital Costs | 1 | 2013 | 63 | 0.410 |
Why?
|
Direct Service Costs | 1 | 2012 | 4 | 0.410 |
Why?
|
Attitude to Health | 1 | 2013 | 92 | 0.400 |
Why?
|
Perception | 2 | 2020 | 75 | 0.390 |
Why?
|
Premature Birth | 2 | 2023 | 11 | 0.390 |
Why?
|
Breast | 2 | 2008 | 20 | 0.380 |
Why?
|
Risk Factors | 7 | 2016 | 2246 | 0.370 |
Why?
|
Reproducibility of Results | 10 | 2006 | 670 | 0.360 |
Why?
|
Nurse's Role | 5 | 2007 | 104 | 0.360 |
Why?
|
United States | 10 | 2020 | 1981 | 0.350 |
Why?
|
Incidence | 6 | 2020 | 714 | 0.350 |
Why?
|
Nurseries, Hospital | 2 | 2007 | 3 | 0.330 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 291 | 0.320 |
Why?
|
Clinical Nursing Research | 2 | 2002 | 7 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2017 | 166 | 0.310 |
Why?
|
Diet | 3 | 2018 | 171 | 0.310 |
Why?
|
Cognition | 2 | 2017 | 1301 | 0.310 |
Why?
|
Lipids | 2 | 2006 | 28 | 0.310 |
Why?
|
Qualitative Research | 4 | 2017 | 102 | 0.300 |
Why?
|
Child, Preschool | 2 | 2020 | 589 | 0.300 |
Why?
|
Animals | 7 | 2020 | 3391 | 0.300 |
Why?
|
Child | 4 | 2021 | 1229 | 0.300 |
Why?
|
Body Weight | 6 | 1996 | 121 | 0.300 |
Why?
|
Biomarkers | 3 | 2020 | 551 | 0.300 |
Why?
|
Anxiety | 2 | 2019 | 136 | 0.290 |
Why?
|
Maternal Age | 3 | 2019 | 13 | 0.270 |
Why?
|
Interviews as Topic | 3 | 2017 | 123 | 0.270 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 34 | 0.270 |
Why?
|
Residence Characteristics | 2 | 2019 | 210 | 0.270 |
Why?
|
Maternal-Child Nursing | 2 | 2004 | 5 | 0.260 |
Why?
|
Centrifugation | 1 | 2006 | 4 | 0.260 |
Why?
|
Colostrum | 3 | 2010 | 5 | 0.260 |
Why?
|
Decision Making | 4 | 2015 | 222 | 0.250 |
Why?
|
Milk Ejection | 3 | 2011 | 3 | 0.250 |
Why?
|
Research | 1 | 2005 | 35 | 0.240 |
Why?
|
Child Nutrition Sciences | 1 | 2005 | 3 | 0.240 |
Why?
|
Adolescent | 7 | 2017 | 2064 | 0.240 |
Why?
|
Parent-Child Relations | 1 | 2004 | 33 | 0.240 |
Why?
|
Evidence-Based Practice | 2 | 2016 | 78 | 0.240 |
Why?
|
Cohort Studies | 6 | 2020 | 1829 | 0.230 |
Why?
|
Mass Media | 1 | 2004 | 8 | 0.230 |
Why?
|
Parents | 1 | 2004 | 104 | 0.220 |
Why?
|
Nursing Evaluation Research | 4 | 2015 | 42 | 0.220 |
Why?
|
Pregnancy | 7 | 2019 | 310 | 0.220 |
Why?
|
Financing, Government | 1 | 2003 | 10 | 0.220 |
Why?
|
Nutritional Status | 2 | 2020 | 49 | 0.210 |
Why?
|
Health Policy | 1 | 2003 | 49 | 0.210 |
Why?
|
Aftercare | 3 | 2018 | 24 | 0.210 |
Why?
|
Cost of Illness | 2 | 2013 | 46 | 0.200 |
Why?
|
Nutritional Support | 3 | 2018 | 24 | 0.200 |
Why?
|
Attitude of Health Personnel | 2 | 2013 | 127 | 0.190 |
Why?
|
Oxidative Stress | 2 | 2018 | 98 | 0.180 |
Why?
|
Age Factors | 2 | 2020 | 744 | 0.180 |
Why?
|
Health Expenditures | 1 | 2020 | 18 | 0.180 |
Why?
|
Neonatology | 1 | 2020 | 4 | 0.180 |
Why?
|
Nipples | 1 | 2000 | 1 | 0.180 |
Why?
|
Protective Devices | 1 | 2000 | 1 | 0.180 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 125 | 0.170 |
Why?
|
Tissue Donors | 2 | 2021 | 77 | 0.170 |
Why?
|
Linear Models | 3 | 2017 | 240 | 0.170 |
Why?
|
Child of Impaired Parents | 1 | 2019 | 11 | 0.170 |
Why?
|
Time Factors | 6 | 2018 | 1364 | 0.170 |
Why?
|
Body Mass Index | 1 | 2021 | 412 | 0.160 |
Why?
|
Directive Counseling | 1 | 2019 | 13 | 0.160 |
Why?
|
Intestinal Mucosa | 2 | 2018 | 183 | 0.160 |
Why?
|
Intention | 1 | 2019 | 22 | 0.160 |
Why?
|
Pregnancy Complications | 1 | 2019 | 48 | 0.160 |
Why?
|
Obesity | 1 | 2021 | 277 | 0.160 |
Why?
|
Acute Disease | 1 | 2019 | 189 | 0.160 |
Why?
|
Inflammation | 2 | 2018 | 265 | 0.160 |
Why?
|
Program Evaluation | 2 | 2013 | 124 | 0.160 |
Why?
|
Toxoplasmosis, Congenital | 2 | 2011 | 8 | 0.160 |
Why?
|
Pilot Projects | 2 | 2018 | 378 | 0.160 |
Why?
|
Return to Work | 2 | 2016 | 62 | 0.160 |
Why?
|
Feeding Methods | 2 | 2013 | 4 | 0.160 |
Why?
|
Depression | 2 | 2019 | 408 | 0.160 |
Why?
|
Social Class | 1 | 2019 | 64 | 0.160 |
Why?
|
Multivariate Analysis | 2 | 2017 | 295 | 0.150 |
Why?
|
Follow-Up Studies | 2 | 2020 | 1713 | 0.150 |
Why?
|
Biomedical Research | 2 | 2016 | 60 | 0.150 |
Why?
|
Cell Death | 1 | 2018 | 44 | 0.150 |
Why?
|
Sucking Behavior | 2 | 1994 | 2 | 0.150 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 74 | 0.140 |
Why?
|
Nervous System | 1 | 2017 | 10 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 340 | 0.140 |
Why?
|
Neurodevelopmental Disorders | 1 | 2017 | 19 | 0.140 |
Why?
|
Eating | 2 | 2011 | 46 | 0.140 |
Why?
|
Narration | 1 | 2017 | 9 | 0.140 |
Why?
|
Pregnancy in Adolescence | 1 | 2017 | 13 | 0.140 |
Why?
|
Tissue and Organ Procurement | 1 | 2016 | 31 | 0.140 |
Why?
|
Tertiary Care Centers | 1 | 2017 | 62 | 0.140 |
Why?
|
Science | 1 | 1996 | 3 | 0.130 |
Why?
|
Nurse-Patient Relations | 2 | 2015 | 34 | 0.130 |
Why?
|
Program Development | 2 | 2014 | 61 | 0.130 |
Why?
|
Weaning | 1 | 2016 | 5 | 0.130 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 138 | 0.130 |
Why?
|
Nutrition Assessment | 1 | 1996 | 34 | 0.130 |
Why?
|
Illinois | 1 | 2016 | 227 | 0.130 |
Why?
|
Informed Consent | 1 | 2015 | 19 | 0.130 |
Why?
|
Severity of Illness Index | 1 | 2019 | 930 | 0.130 |
Why?
|
Guidelines as Topic | 1 | 2016 | 62 | 0.130 |
Why?
|
Nigeria | 2 | 2007 | 3 | 0.130 |
Why?
|
Bacteria | 1 | 2016 | 74 | 0.130 |
Why?
|
Chondroitinases and Chondroitin Lyases | 1 | 2015 | 4 | 0.130 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 52 | 0.130 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2015 | 15 | 0.130 |
Why?
|
Incubators, Infant | 2 | 1995 | 2 | 0.120 |
Why?
|
Life Change Events | 1 | 2015 | 31 | 0.120 |
Why?
|
Length of Stay | 1 | 2017 | 302 | 0.120 |
Why?
|
Home Nursing | 1 | 1994 | 18 | 0.120 |
Why?
|
Ambulatory Care | 1 | 2015 | 68 | 0.120 |
Why?
|
Beds | 1 | 1994 | 2 | 0.120 |
Why?
|
Focus Groups | 1 | 1994 | 82 | 0.110 |
Why?
|
Morbidity | 1 | 2014 | 55 | 0.110 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 485 | 0.110 |
Why?
|
Milk | 2 | 2012 | 14 | 0.110 |
Why?
|
Swine | 1 | 2013 | 62 | 0.110 |
Why?
|
Nursing Staff, Hospital | 2 | 1993 | 43 | 0.110 |
Why?
|
Patient Readmission | 1 | 2015 | 130 | 0.110 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 36 | 0.110 |
Why?
|
Models, Animal | 1 | 2013 | 106 | 0.110 |
Why?
|
Clinical Chemistry Tests | 2 | 2006 | 4 | 0.110 |
Why?
|
Gastrointestinal Microbiome | 1 | 2016 | 172 | 0.110 |
Why?
|
Guilt | 1 | 2013 | 2 | 0.110 |
Why?
|
Surveys and Questionnaires | 3 | 2015 | 1066 | 0.110 |
Why?
|
Organizational Culture | 1 | 2013 | 19 | 0.110 |
Why?
|
Propensity Score | 1 | 2013 | 31 | 0.110 |
Why?
|
Quality Improvement | 1 | 2014 | 150 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2012 | 7 | 0.100 |
Why?
|
Morphogenesis | 1 | 2012 | 8 | 0.100 |
Why?
|
Motivation | 1 | 2013 | 92 | 0.100 |
Why?
|
Quadruplets | 1 | 1992 | 1 | 0.100 |
Why?
|
Microbiota | 1 | 2013 | 101 | 0.100 |
Why?
|
Body Height | 1 | 1992 | 33 | 0.100 |
Why?
|
Food Contamination | 1 | 2011 | 3 | 0.100 |
Why?
|
Toxoplasma | 1 | 2011 | 7 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 117 | 0.090 |
Why?
|
Reference Values | 1 | 2011 | 184 | 0.090 |
Why?
|
Immunoglobulin A, Secretory | 1 | 2010 | 4 | 0.090 |
Why?
|
Lactoferrin | 1 | 2010 | 6 | 0.090 |
Why?
|
Treatment Outcome | 1 | 2019 | 3293 | 0.090 |
Why?
|
Cultured Milk Products | 1 | 2009 | 3 | 0.090 |
Why?
|
Models, Nursing | 2 | 2004 | 27 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 186 | 0.080 |
Why?
|
Infant Food | 2 | 2004 | 2 | 0.080 |
Why?
|
Personal Satisfaction | 1 | 2008 | 40 | 0.080 |
Why?
|
Observer Variation | 6 | 2000 | 93 | 0.070 |
Why?
|
Equipment Design | 2 | 2007 | 141 | 0.070 |
Why?
|
Midwifery | 1 | 2007 | 1 | 0.070 |
Why?
|
Nursing Diagnosis | 1 | 2007 | 2 | 0.070 |
Why?
|
Kenya | 1 | 2007 | 11 | 0.070 |
Why?
|
Models, Biological | 1 | 2009 | 304 | 0.070 |
Why?
|
Data Collection | 2 | 2002 | 91 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2007 | 253 | 0.070 |
Why?
|
North America | 2 | 2018 | 36 | 0.060 |
Why?
|
Risk Management | 1 | 2005 | 5 | 0.060 |
Why?
|
Ethics, Research | 1 | 2005 | 3 | 0.060 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2005 | 1 | 0.060 |
Why?
|
Toxoplasmosis | 1 | 2005 | 5 | 0.060 |
Why?
|
Object Attachment | 1 | 2004 | 1 | 0.060 |
Why?
|
Prenatal Diagnosis | 1 | 2005 | 15 | 0.060 |
Why?
|
Nursing Assessment | 1 | 2005 | 28 | 0.060 |
Why?
|
Nursing Methodology Research | 1 | 2004 | 21 | 0.060 |
Why?
|
Logistic Models | 2 | 2016 | 362 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2005 | 58 | 0.060 |
Why?
|
Clinical Protocols | 2 | 2014 | 55 | 0.060 |
Why?
|
Health Planning Support | 1 | 2003 | 1 | 0.050 |
Why?
|
Healthy People Programs | 1 | 2003 | 2 | 0.050 |
Why?
|
Databases, Bibliographic | 1 | 2003 | 7 | 0.050 |
Why?
|
Politics | 1 | 2003 | 10 | 0.050 |
Why?
|
Policy Making | 1 | 2003 | 14 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2003 | 23 | 0.050 |
Why?
|
Conflict of Interest | 1 | 2003 | 12 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2003 | 202 | 0.050 |
Why?
|
Holistic Nursing | 1 | 2002 | 2 | 0.050 |
Why?
|
Cross Infection | 1 | 2005 | 277 | 0.050 |
Why?
|
Research Design | 1 | 2002 | 181 | 0.040 |
Why?
|
Silicones | 1 | 2000 | 9 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 305 | 0.040 |
Why?
|
Risk | 1 | 2020 | 199 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2020 | 72 | 0.040 |
Why?
|
Evaluation Studies as Topic | 3 | 1994 | 35 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2020 | 99 | 0.040 |
Why?
|
Administration, Oral | 2 | 2010 | 100 | 0.040 |
Why?
|
Single-Blind Method | 2 | 1996 | 105 | 0.040 |
Why?
|
Oceania | 1 | 2018 | 3 | 0.040 |
Why?
|
Asia | 1 | 2018 | 10 | 0.040 |
Why?
|
Africa | 1 | 2018 | 9 | 0.040 |
Why?
|
Europe | 1 | 2018 | 65 | 0.040 |
Why?
|
North Carolina | 1 | 2018 | 5 | 0.040 |
Why?
|
Internationality | 1 | 2018 | 24 | 0.040 |
Why?
|
Databases, Factual | 1 | 2020 | 325 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2020 | 550 | 0.040 |
Why?
|
Food, Fortified | 1 | 2018 | 6 | 0.040 |
Why?
|
F2-Isoprostanes | 1 | 2018 | 7 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2018 | 56 | 0.040 |
Why?
|
Income | 1 | 2018 | 73 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 103 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 186 | 0.040 |
Why?
|
Patient Outcome Assessment | 1 | 2017 | 38 | 0.030 |
Why?
|
Health | 1 | 1996 | 9 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2016 | 39 | 0.030 |
Why?
|
Phylogeny | 1 | 2016 | 46 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2016 | 52 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 43 | 0.030 |
Why?
|
Feces | 1 | 2016 | 105 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2015 | 9 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2015 | 11 | 0.030 |
Why?
|
Biological Availability | 1 | 2015 | 19 | 0.030 |
Why?
|
NF-kappa B | 1 | 2015 | 108 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2015 | 200 | 0.030 |
Why?
|
Cell Line | 1 | 2015 | 245 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 75 | 0.030 |
Why?
|
Transportation of Patients | 1 | 1994 | 4 | 0.030 |
Why?
|
Group Processes | 1 | 1994 | 8 | 0.030 |
Why?
|
Research Personnel | 1 | 1994 | 19 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 1994 | 30 | 0.030 |
Why?
|
Nurse Clinicians | 1 | 1994 | 23 | 0.030 |
Why?
|
Consultants | 1 | 1993 | 1 | 0.030 |
Why?
|
Workload | 1 | 1993 | 29 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 2012 | 1 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2012 | 38 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2012 | 10 | 0.030 |
Why?
|
Cesarean Section | 1 | 1992 | 28 | 0.020 |
Why?
|
Fetal Development | 1 | 2012 | 1 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 66 | 0.020 |
Why?
|
Oocysts | 1 | 2011 | 2 | 0.020 |
Why?
|
Antibodies, Protozoan | 1 | 2011 | 5 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 29 | 0.020 |
Why?
|
Immunoassay | 1 | 2011 | 37 | 0.020 |
Why?
|
Patient Care Team | 1 | 1993 | 132 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 28 | 0.020 |
Why?
|
Mice | 1 | 2015 | 1281 | 0.020 |
Why?
|
Bodily Secretions | 1 | 2010 | 1 | 0.020 |
Why?
|
Methods | 1 | 1990 | 11 | 0.020 |
Why?
|
Weights and Measures | 1 | 1990 | 6 | 0.020 |
Why?
|
Cephalometry | 1 | 1989 | 4 | 0.020 |
Why?
|
Trachea | 1 | 2010 | 45 | 0.020 |
Why?
|
Equipment and Supplies | 1 | 1989 | 9 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 457 | 0.020 |
Why?
|
Prognosis | 1 | 2009 | 750 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2005 | 77 | 0.020 |
Why?
|
Sampling Studies | 1 | 2004 | 26 | 0.020 |
Why?
|
Urban Population | 1 | 2004 | 143 | 0.010 |
Why?
|
Electronics | 2 | 1995 | 7 | 0.010 |
Why?
|
Safety | 1 | 2002 | 39 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2000 | 27 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2000 | 399 | 0.010 |
Why?
|
Critical Illness | 1 | 1995 | 122 | 0.010 |
Why?
|
Transducers, Pressure | 1 | 1992 | 4 | 0.010 |
Why?
|